|
64 |
Genematrix received project for Zika virus vaccine developme…
|
2016.09.29 |
|
63 |
Agreement on the development of new/variant respiratory path…
|
2016.09.05 |
|
62 |
Genematrix acquired European patent for gene amplification m…
|
2016.07.11 |
|
61 |
Genematrix commercializes early diagnosis products for myoca…
|
2016.05.11 |
|
60 |
Genematrix secured proprietary technology for next-generatio…
|
2016.04.25 |
|
59 |
Genematrix secured advanced prediction technology for respon…
|
2016.03.23 |
|
58 |
Reimbursement : Hepatitis B drug resistance diagnosis produc…
|
2015.04.20 |
|
57 |
The 27th Health Technology (HT) Forum-Future Medical Mega Tr…
|
2014.06.25 |
|
56 |
Predictive diagnosis method for Hepatitis B treatment drug r…
|
2014.05.27 |
|
55 |
Genematrix registered a patent for the cervical cancer diagn…
|
2014.05.26 |
|
54 |
Genematrix registered a patent for early diagnosis method of…
|
2014.05.08 |
|
53 |
No. 1 product in sales, 'Baraclude' is approved for resistan…
|
2014.04.14 |
|
52 |
Genematrix successfully proved clinical efficacy of cervical…
|
2014.03.14 |
|
51 |
Genematrix patented anticancer drug derived from natural pro…
|
2014.02.05 |
|
50 |
Genematrix attends Arab Health 2014 in Dubai
|
2014.01.20 |
ENG